Macular Society: Treatment trial for Stargardt diseases reaches the UK

12 February 2018
Source: Macular Society

Researchers in the south of England will become the first in the UK to trial a new drug that could prevent sight loss caused by Stargardt disease, a currently untreatable condition. Stargardt disease, also known as Stargardt macular dystrophy, affects the area of the retina called the macula and causes a reduction in central vision. It is the most common form of juvenile macular

Read more Macular Society: Treatment trial for Stargardt diseases reaches the UK